Rationale: Endothelial cells (EC) at regions exposed to disturbed flow (d-flow) are predisposed to inflammation and the subsequent development of atherosclerosis. We previously showed that thioredoxin interacting protein (TXNIP) was required for tumor necrosis factor-mediated expression of vascular cell adhesion molecule-1.
A therosclerotic lesions occur in a nonrandom pattern characterized by preferential initiation at sites of disturbed blood flow (d-flow) as compared to regions of steady flow (s-flow). Specifically, atherosclerosis is prominent in d-flow regions such as the lesser curvature of the aortic arch, flow dividers, and branch points. [1] [2] [3] Fluid shear stress, the frictional force generated by blood flow, mechanically acts on endothelial cells (EC) in the vasculature and regulates EC functions. Physiological s-flow present within straight segments of the arterial tree, is of high shear stress (Ͼ10 dyn/cm 2 ) and athero-protective. 4, 5 In contrast, d-flow, characterized by a nonunidirectional, nonsteady flow pattern with a low magnitude of shear stress (Ͻ5 dyn/cm 2 ), 4, 6 promotes endothelial dysfunction by increasing intracellular reactive oxygen species (ROS) production, 7 endothelial permeability, 8 and the expression of cell adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1). 9 The induction of these cell adhesion molecules in response to d-flow leads to increased binding of circulating leukocytes, which transmigrate across the EC, create chronic inflammation, and promote atherogenesis. 10 The mechanisms by which s-flow increases atheroprotective gene expression have been shown to be mediated primarily (proximately 70%) by a MEK5-ERK5-KLF2 pathway. 11 Kruppel-like factor 2 (KLF2) is a key antiinflammatory transcription factor in EC 11, 12 and is exclusively induced by s-flow but not by d-flow. 13 Specifically, KLF2 has been shown to enhance the expression of anti-inflammatory genes such as endothelial nitric oxide synthase (eNOS) on one hand, and inhibit the induction of cell adhesion molecules by cytokines on the other. 12 In contrast, less is known regarding specific d-flow mechanisms. Our laboratory and others have shown that d-flow is associated with increased PKC activity 14 and p53 activation. 15 Previously, we reported that EC thioredoxin interacting protein (TXNIP, also termed as TBP-2) was reduced by s-flow, thereby increasing thioredoxin activity and suppressing EC inflammation in response to tumor necrosis factor-␣ via inhibiting JNK and p38 signaling pathways. 16 TXNIP has multiple functions in EC by regulating metabolism, 17 cell growth, 18 and inflammation. 19 TXNIP is a member of ␣-arrestin family 20 and acts as a scaffold for several proteins besides thioredoxin, 21 including NLRP3 19 and histone deacetylase (HDAC). 18, 22 However, the role of TXNIP in d-flow-induced EC dysfunction has not been investigated. In the present study, we show that the increase of TXNIP is required for d-flow-induced cell adhesion molecule expression and leukocyte adhesion. Furthermore, we show that TXNIP promotes EC dysfunction by acting as a transcriptional corepressor of the KLF2 promoter to inhibit KLF2 expression and its downstream signaling.
Methods
An expanded Methods section is provided in the online-only Data Supplement.
Animals
All animal experiments were conducted in accordance with experimental protocols that were approved by the University Committee on Animal Resources of the University of Rochester. To generate EC-specific TXNIP knockout mice, female TXNIP flox/flox mice (made by Dr Roger Davis, San Diego State University) were crossed with male Cre recombinase transgenic mice under the control of endothelial-specific receptor tyrosine kinase 2 (Tie2) promoter (Tie2-Cre ϩ , purchased from Jackson Laboratory, #4128) to generate heterozygous Tie2-Cre ϩ TXNIP flox/Ϫ mice for breeding. Then homozygous EC-specific TXNIP knockout mice (Tie2-Cre ϩ TXNIP flox/flox ) were obtained and the Cre negative littermates (Tie2-Cre Ϫ TXNIP flox/flox ) were used as controls. Animals were maintained under pathogen-free conditions of the Aab Cardiovascular Research Institute of the University of Rochester.
Cell Culture
Human umbilical vein endothelial cells (HUVEC) were cultured as detailed in the online-only Data Supplement.
Plasmid and siRNA Oligonucleotide Transfection
HUVEC were transfected with TXNIP-green fluorescent protein, TXNIP specific siRNA, or luciferase reporter gene constructs as detailed in the online-only Data Supplement.
Flow Apparatus
Confluent HUVEC cultured in 35-mm dishes were exposed to s-and d-flow at 37°C in a humidified 5% CO 2 tissue culture incubator using a parallel-plate flow chamber (GlycoTech, Gaithersburg, MD). Cutouts (1 mmϫ1 mm) were made on both sides of the silastic gasket to create shear gradients and vortices within the flow path. 23 When culture medium was circulated through the chamber using a peristaltic pump (EP-1 Econo Pump, Bio-Rad, Hercules, CA), cells in the main, central part of the flow chamber were exposed to s-flow (12 dyn/cm 2 ) while small disturbed flow areas were created within the cutouts. Shear stress in the s-flow region was calculated by the formula 6Q/wh 2 , where Q is the flow rate, is the fluid viscosity, w is the width of the channel, and h is the thickness of the gasket. After 24 hours, EC in the cutout area exhibited polygonal cell shapes, whereas cells in the middle part of chamber were aligned parallel to the direction of flow. To expose a large amount of cells to flow for biochemical studies, we used a cone-and-plate flow apparatus as described previously. 15, 16 Confluent HUVEC cultured in 100-mm dishes were exposed to s-flow at 12 dyn/cm 2 by using smooth cones, 16 or exposed to d-flow by using grooved cones at 5 rpm (gives 0.6 dyn/cm 2 of s-flow) for the indicated times. 15, 16 The shear stress imposed on the surface of the plate was calculated by the formula / where is the rotation speed, is the fluid viscosity, and is the angle of the cone.
Luciferase Assay
The luciferase activities of the KLF2 promoter and NF-B binding site were assayed as detailed in the online-only Data Supplement.
En Face Immunofluorescence Staining
En face immunofluorescence staining of mouse aorta to compare TXNIP expression in different regions (s-flow versus d-flow) was performed as detailed in the online-only Data Supplement.
In Vitro THP-1 Monocyte Adhesion Assay
EC-monocyte adhesion was assayed by coincubating fluorescently labeled THP-1 monocytes with HUVEC as detailed in the onlineonly Data Supplement.
Intravital Microscopy
Age-matched male EC-TXNIP knockout and control mice (3-5 months) were anesthetized by intraperitoneal injection of ketamine/ 
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Real-Time Quantitative Polymerase Chain Reaction
Relative mRNA expression of VCAM-1, ICAM-1, and KLF2 was quantified by real-time polymerase chain reaction (PCR) as detailed in the online-only Data Supplement.
Western Blot Analysis
Protein expression of TXNIP, VCAM-1, ICAM-1, KLF2, and eNOS was quantified by Western blot as detailed in the online-only Data Supplement.
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation assay (ChIP) assay to investigate the association of TXNIP with the KLF2 promoter was performed as detailed in the online-only Data Supplement.
Statistical Analysis
Data are shown as meanϮSD from 3 to 7 independent experiments. Leukocyte rolling events were compared by using Mann-Whitney U test. Other differences were analyzed by two-tailed Student t-test. Probability values Ͻ0.05 were considered statistically significant.
Results
Disturbed Flow Increases TXNIP Expression in EC
To study the effect of d-flow on TXNIP expression, we performed en face immunofluorescence staining on mouse aorta to compare EC TXNIP expression levels under different flow patterns. We found TXNIP was dramatically increased in d-flow regions, including the lesser curvature of the aortic arch (area L in Figure 1A and 1B) and the branch points of outflow tracts (bottom panel in Figure 1A , Online Figure I , and the corresponding blue area in Figure 1B ), when compared with nearby athero-protective s-flow regions, such as the greater curvature (area G in Figure 1A and 1B) and the main segment of the thoracic aorta (bottom panel in Figure  1A ) both from C57BL/6 wild type and ApoE Ϫ/Ϫ mice. To confirm the increase of TXNIP expression by d-flow in vitro, we used a parallel flow chamber with cutouts ( Figure 1C ) that creates adjacently located d-and s-flow areas. After 24 hours of flow treatment (12 dyn/cm 2 in the s-flow region), a greater expression of TXNIP in HUVEC was observed in the d-flow cutout area than in the s-flow region ( Figure 1D and 1E). Subcellular fractionation further showed that the increase of TXNIP in response to d-flow mainly occurred in the nucleus (Online Figure II) . These results suggest that TXNIP is a mechano-sensitive gene that is highly increased in EC by d-flow both in vivo and in vitro. D and E, HUVEC cultured in the flow chamber were exposed for 24 hours to flow that was calculated to yield shear stress of 12 dyn/cm 2 in the s-flow region. TXNIP expression was assayed by immunofluorescence. EC morphology is shown by VE-Cadherin staining.
TXNIP is Required for D-Flow-Induced Cell Adhesion Molecule Expression and EC-Monocyte Adhesion
A key reason that d-flow promotes atherosclerosis is the pronounced expression of cell adhesion molecules on the endothelial surface (Online Figure III) , 24, 25 which facilitates leukocyte recruitment and vascular inflammation. To investigate whether TXNIP plays a role in this process, we established EC-specific TXNIP knockout (EC-TXNIP KO) mice by using Cre/LoxP strategy. We generated Tie2-Cre ϩ TXNIP flox/flox mice as knockout mice and Tie2-Cre -TXNIP flox/flox littermates as controls (Online Figure IV) . Then real-time PCR was performed to determine if TXNIP regulates cell adhesion molecule expression. We found that in control animals, VCAM-1 (9.75Ϯ2.99-fold) and ICAM-1 (2.15Ϯ0.23-fold) mRNA expression levels were markedly increased in the lesser curvature of the aortic arch where the flow pattern is disturbed, as compared to the thoracic aorta where the majority of EC are under s-flow (Figure 2A and 2B). Importantly, the increased expression of these cell adhesion molecules in the d-flow area was significantly inhibited in EC-TXNIP KO mice (Figure 2A and 2B) . In vitro knockdown of TXNIP also showed dramatic decreases in VCAM-1 and ICAM-1 expression under d-flow ( Figure 2C ).
Next, we performed an in vitro adhesion assay to show that TXNIP plays a role in the enhanced EC-leukocyte adhesion under d-flow. HUVEC cultured in the cutout chamber were exposed to flow for 24 hours and then coincubated with prelabeled THP-1 monocytes. In the control group transfected with scramble control siRNA, there was a Ͼ3-fold increase in adherent monocytes in the d-flow cutout area as compared to the adjacent s-flow region (Figure 3) . Importantly, ECmonocyte interactions in response to d-flow were significantly reduced after TXNIP knockdown (Figure 3 ). In contrast, the inhibition of EC-monocyte binding by s-flow was virtually abolished in the presence of TXNIP overexpression (Online Figure V) .
TXNIP Deficiency in EC Reduces Leukocyte-Endothelium Adhesiveness
Leukocyte adhesion to endothelium is one of the earliest steps in atherogenesis, which involves the initial attachment of circulating leukocytes, capture, and subsequent firm adherence. Similar as the d-flow area in the conduit artery, the venous system is exposed to low shear stress ranging from 1 to 6 dyn/cm 2 . 4 Moreover, intravital microscopy of mesenteric venules is an established method to analyze leukocyte-endothelium interactions. Thus, to study the role of TXNIP in leukocyte adhesion in vivo, we performed intravital microscopy to quantify leukocyte rolling time and rolling velocity in mesenteric venules (nϭ7) from control (Tie2-Cre Ϫ TXNIP flox/flox ) and EC-TXNIP KO (Tie2-Cre ϩ TXNIP flox/flox ) mice. Leukocyte movement was monitored in real time ( Figure 4A ). Compared with control animals, significant decreases in rolling time ( Figure 4B ) and marked increases in rolling velocity ( Figure 4C ) of fluorescently labeled leukocytes were observed in EC-TXNIP KO mice. Especially, the number of leukocytes with long rolling time (5 s-20 s) was substantially decreased in EC-TXNIP KO mice ( Figure 4D ). In addition, no significant difference in ECleukocyte adhesion was detected between Tie2-Cre Ϫ TXNIP flox/flox and Tie2-Cre ϩ transgenic mice (data not shown), which confirms that the decrease of endothelial adhesiveness in EC-TXNIP KO mice is due to the depletion of TXNIP but not Cre toxicity. Comparison of the 2 strains showed no changes in systolic blood pressure (Online Figure  VIA) , heart rate (Online Figure VIB) , and TXNIP expression in peripheral blood mononuclear cells (Online Figure VII) . Taken together, these results clearly show that TXNIP deficiency reduces leukocyte adhesion to endothelium, which confirms the role of TXNIP in modulating the expression of proinflammatory cell adhesion molecules.
TXNIP Suppresses KLF2 Expression and Promoter Activity
KLF2 has been reported to be an important anti-inflammatory transcription factor in EC. 12 It is highly induced by s-flow but not by d-flow, 13 and antagonizes the induction of cell adhesion molecules in response to tumor necrosis factor-␣ and IL-1␤ in EC. 12 Thus, we next hypothesized that KLF2 is regulated by TXNIP in EC in a flow-dependent manner. We found KLF2 expression was decreased by d-flow ( Figure  5A ). Moreover, overexpression of KLF2 virtually abolished the d-flow-induced VCAM-1 and ICAM-1 expression (Figure 5A ), suggesting that the inhibition of KLF2 by d-flow is required for cell adhesion molecule expression.
Next, we found that KLF2 mRNA levels in the lesser curvature of the aortic arch (d-flow region) were significantly increased in EC-TXNIP KO mice by using real-time PCR ( Figure 5B ). Furthermore, knockdown of TXNIP in vitro increased KLF2 protein levels under both static condition and d-flow ( Figure 5C ). KLF2 has been previously reported to prevent NF-B activation. 26 We also found that the d-flowinduced NF-B activation was completely abolished after TXNIP knockdown (Online Figure VIII) . On the other hand, overexpression of TXNIP significantly reduced KLF2 protein ( Figure 5D ) and mRNA ( Figure 5E ) expression levels under both static condition and s-flow. In addition, the expression of eNOS, a downstream target of KLF2 in EC, was also decreased by TXNIP overexpression (Online Figure IXA) .
To establish the mechanism by which TXNIP inhibits KLF2 expression, we studied the effect of TXNIP on KLF2 promoter activity by using luciferase assay. TXNIP overexpression significantly decreased the activity of both the Ϫ924 bp full-length promoter and the Ϫ157 bp fragment, whereas a further deletion of the promoter (Ϫ78 bp construct) resulted in complete loss of inhibition ( Figure 6A) . These data suggest that the TXNIP-mediated repression occurs through a region from Ϫ157 bp to Ϫ78 bp of the KLF2 promoter. The Ϫ157 bp promoter fragment was previously reported to be responsible for the transactivation of KLF2 by s-flow. 27 Thus, we further investigated whether the inhibition persisted after 5 and 7) and control littermates (panels 1 and 3) . The recorded videos were processed by Image-Pro into a simplified form for the automatic recognition and tracking of rolling leukocytes. The corresponding processed images are also shown (panels 6 and 8, and panels 2 and  4) . B and C, Whisker plots showing the leukocyte rolling time (B) and rolling velocity (C) from both animal groups after log transformation. Median, quartiles, and extreme values are given. Significant differences between 2 animal groups were tested using Mann-Whitney U test. (D) Further analysis of the quantified data for slow moving leukocytes with rolling time Ͼ5 s. Percentage of leukocytes with indicated rolling times was calculated correspondingly by using frequency table. Data are expressed as meanϮSD from 7 mice in each group. *PϽ0.05. s-flow exposure. We detected a 4.13Ϯ0.13-fold increase for the Ϫ924 bp promoter construct ( Figure 6B ) and a 2.61Ϯ0.11-fold increase for the Ϫ157 bp promoter construct ( Figure 6C ) in luciferase activity after s-flow treatment, whereas the increase of promoter activity by s-flow was significantly repressed in the presence of TXNIP overexpression for both promoters. Taken together, these results suggest a role for TXNIP as a corepressor of the KLF2 promoter, thereby inhibiting KLF2 expression and its downstream signaling. These data are consistent with the reports that TXNIP associates with transcriptional repressors such as HDAC1 and HDAC3. 18, 22 
Association of TXNIP With the KLF2 Promoter Is Increased by D-Flow and Reduced by S-Flow
Based on our luciferase assay results, we proposed that TXNIP is a transcriptional corepressor of the KLF2 promoter. To test this, ChIP assays were performed to analyze the association of TXNIP with the KLF2 promoter under different flow conditions. There was a significant increase in TXNIP-KLF2 promoter complex when cells were exposed to d-flow (peak increase of 4.04Ϯ0.53-fold at 24 hours, Figure  7A and 7C). In contrast, this complex was decreased by s-flow exposure (peak decrease of 0.20Ϯ0.11-fold at 24 hours, Figure 7B and 7C). Next, we showed that d-flow treatment altered protein expression in a manner consistent with the ChIP results: increased TXNIP by 1.93Ϯ0.19-fold and decreased KLF2 by 0.59Ϯ0.09-fold at 24 hours ( Figure  7D and 7E) . A mild decrease in eNOS expression after d-flow exposure was also observed ( Figure IXB) . Taken together, these results indicate that TXNIP is a member of the transcriptional repressing complex localized on the KLF2 promoter ( Figure 7F ). This complex is increased by d-flow and decreased by s-flow, which finally leads to the deactivation or activation of KLF2 transcription and its downstream signaling.
Discussion
The major findings of the present study are that TXNIP expression is increased by d-flow, inhibits KLF2 expression, and promotes endothelial-leukocyte adhesion; thereby initi- C, HUVEC were transfected with either scramble control or TXNIP-specific siRNA for 48 hours. Then EC were exposed to d-flow or kept at static condition for an additional 24 hours. Protein expression of KLF2 and TXNIP was analyzed by Western blot. D and E, To demonstrate that TXNIP inhibits KLF2 expression, HUVEC in 100-mm dish were transfected with 3 g TXNIP-green fluorescent protein (GFP) or control plasmid, and exposed to s-flow or kept at static condition for 24 hours for protein harvest (D) or 6 hours for RNA harvest (E). D, KLF2 protein expression levels were then analyzed by Western blot. E, KLF2 mRNA levels were quantified by real-time PCR and are expressed as meanϮSD of 3 independent experiments. *PϽ0.05.
Figure 6. Thioredoxin interacting protein (TXNIP) suppresses
Kruppel-like factor 2 (KLF2) promoter activity. A, Various deletion constructs (Ϫ924 bp, Ϫ157 bp, and Ϫ78 bp) of the KLF2 promoter were cotransfected with TXNIP-green fluorescent protein (GFP) or control plasmid into human umbilical vein endothelial cells (HUVEC). After 24 hours of transfection, cells were harvested and the luciferase activities were measured. B and C, HUVEC were cotransfected with either TXNIP-GFP or control plasmid, and Ϫ924 bp (B) or Ϫ157 bp (C) KLF2 promoter reporter gene construct. After 18 hours of incubation, cells were exposed to s-flow or kept at static condition for 6 hours before harvest for luciferase assay. Results are expressed as meanϮSD of 3 independent experiments. *PϽ0.05.
ating inflammation (Online Figure X) . The ChIP assay data show the mechanism for TXNIP regulation of KLF2 involves the association with the KLF2 promoter. In addition, an important feature of the current study is that we clearly demonstrate by 2 approaches that d-flow athero-prone sites exhibit a dramatic increase of TXNIP expression. First, en face immunohistochemistry shows high TXNIP expression in d-flow areas, which is very similar to PKC as we previously described. 14 Second, in vitro studies of s-flow and d-flow using a cutout chamber under identical tissue culture conditions reproduce the in vivo results. 23 These results lead to the concept that TXNIP is a mechanosensitive switch for EC inflammation by inhibiting athero-protective pathways downstream of KLF2 and activating athero-promoting gene expression.
We propose that TXNIP is a very important regulator of the genetic programs present under s-flow and d-flow by regulation of KLF2. It is likely that s-flow inhibits TXNIP interaction with the KLF2 promoter by 2 mechanisms. First, total TXNIP expression in EC is decreased by s-flow in a chronic manner. 16 Second, s-flow may maintain TXNIP in a cytosolic location that prevents effects on gene transcription. In contrast, d-flow dramatically increases TXNIP expression in the nucleus, which may lead to increased interactions with transcriptional repressors, such as HDAC1 and HDAC3. 18, 22 Thus, TXNIP seems to act as a corepressor by recruiting transcriptional repressors to the transcription factors that are responsible for KLF2 transactivation ( Figure 7F ). Furthermore, we established that the activation of the KLF2 promoter in response to s-flow was virtually abolished by TXNIP overexpression, and a small fragment of the KLF2 promoter (Ϫ157 bp to Ϫ78 bp) was responsible ( Figure 6A ). Analysis of the promoter sequence and a literature survey failed to yield any known binding motif or associated transcription factor. Identification of the precise mechanism of TXNIP corepression will be an important future goal.
Although TXNIP appears to be a common mediator for regulation of s-flow and d-flow gene expression, the mechanisms by which flow regulates TXNIP and KLF2 expression clearly differ. KLF2 expression is regulated by several transcription factors, such as MEF2C, 28 PLZF, 29 and P300 30 or by miRNA post-transcriptionally. 31 Using in situ hybridization, Dekker et al showed that KLF2 is exclusively induced by s-flow but not d-flow. 13 Our study shows a novel mechanism by which KLF2 is differentially regulated that involves transcription corepression by d-flow. Several mechanisms have been shown to regulate TXNIP expression. To date, these fall into either metabolic or redox-sensitive pathways. For example, the MondoA:Mlx dimer transcription factors promote TXNIP expression by activating a carbohydrate response element on the TXNIP promoter. 32 Among the pathways responsive to oxidative stress, both hyperglycemia and d-flow increase intracellular reactive oxygen species levels in EC by activating NAD(P)H oxidase, 7, 33, 34 raising the possibility that a similar mechanism may be responsible for d-flow-induced TXNIP. In addition, Nrf2, an important shear stress-responsive transcription factor regulating redoxsensitive responses, 35 has been shown to significantly increase TXNIP expression. 36 The roles of MondoA:Mlx and Nrf2 as mediators for TXNIP induction by d-flow need further elucidation.
Our findings have several potential clinical implications. First, as shown by intravital microscopy (Figure 4 ), we demonstrated that TXNIP is required for leukocyte interaction with vessel walls, suggesting it is a novel target for preventing leukocyte recruitment. Second, the increase of TXNIP in response to d-flow promotes cell adhesion molecule expression; conversely, this effect is inhibited by overexpression of KLF2. This establishes a counterregulatory role for TXNIP and KLF2, which suggests that a strategy to increase KLF2 or decrease TXNIP should provide therapeutic benefits. Finally, given that diabetes is associated with high TXNIP expression, therapies that decrease TXNIP would be predicted to be useful for reducing complications in diabetics such as accelerated atherosclerosis. 37, 38 
